Pangaea Oncology
BME:PANG
1,70
€0,00 (0,00%)
1,70
€0,00 (0,00%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€-0,03
Earnings Per Share
-
Revenue Per Share
0,00%
Gross Margin %
€0,06 B
Market Cap
€0,00 B
Long-Term Debt
Earnings Per Share
€-0,03
Revenue Per Share
-
Gross Margin %
0,00%
Market Cap
€0,06 B
Long-Term Debt
€0,00 B

Financials

Year Year 2024 2023 2022 2020
EPS Earnings Per Share €-0,03 €-0,03 €-0,03 €-0,10
Earnings Earnings €-0,90M €-0,90M €-0,91M €-1,87M
RPS Revenue Per Share N/A €0,14 €0,14 €0,22
Revenue Revenue €14,56M €4,37M €4,37M €4,10M
OCF Operating Cash Flow €-2,10M €-3,68M €-3,68M €-1,92M
FCF Free Cash Flow €-5,05M €-3,50M €-3,70M €-1,99M
OM Operating Margin 0,00% -34,59% -40,40% -30,51%
GM % Gross Margin % 0,00% 75,92% 59,06% 73,63%
FCFS Free Cash Flow Per Share €0,00 €-0,09 €-0,12 €-0,11
LT Debt Long-Term Debt N/A €0,68M €1,23M €2,19M
Sha. Stocks 29,45M 30,14M 30,44M 18,73M
×